NCT04115202 (ECALAP) is a clinical trial of lumbar arthrodesis in Lumbar Arthrodesis, sponsored by Ramsay Générale de Santé.

Who is sponsoring NCT04115202?

NCT04115202 is sponsored by Ramsay Générale de Santé.

What drugs are being tested in NCT04115202?

Interventions in NCT04115202: lumbar arthrodesis.

What condition does NCT04115202 study?

NCT04115202 studies Lumbar Arthrodesis.

Is NCT04115202 still recruiting?

NCT04115202 is currently status unknown. Last updated 3 October 2019.

Last reviewed 2019-10-03 · How we verify

NCT04115202: ECALAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Study of the Results of Anterior and Posterior Arthrodesis in Degenerative Lumbar Pathology

Status unknown Last updated 3 October 2019

What this trial tests

trial testing lumbar arthrodesis in Lumbar Arthrodesis in 254 participants. Status unknown.

Timeline

31 May 2018

Primary endpoint
31 July 2020

31 July 2020

Quick facts

Lead sponsor	Ramsay Générale de Santé
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	254
Start date	31 May 2018
Primary completion	31 July 2020
Estimated completion	31 July 2020
Sites	1 location across France

Drugs / interventions tested

lumbar arthrodesis

Conditions studied

Lumbar Arthrodesis — all drugs for Lumbar Arthrodesis →

Sponsor

Ramsay Générale de Santé — full company profile →

Who can join

18 and older, any sex, with Lumbar Arthrodesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the functional results through the improvement of the Oswestry medium-term score of the lumbar arthrodesis performed to treat patients with lumbago and/or lumbar-radicular pain due to degenerative lesions of the lumbar spine: degenerative disc disease, osteoarthritis spondylolisthesis or adult dislocation scoliosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ramsay Générale de Santé trials

Trials by the same sponsor.

NCT07353060 — Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT) · NA · not yet recruiting
NCT07245823 — Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineo · NA · recruiting
NCT07142330 — Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries · not yet recruiting
NCT07203131 — Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Ca · NA · recruiting
NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04115202 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ramsay Générale de Santé
Last refreshed: 3 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04115202.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing